Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating atherosclerosis

An atherosclerosis and drug technology, applied in the field of drugs, can solve the problems of less effective drugs and less drugs, and achieve the effects of less adverse reactions, regulating dyslipidemia, and restoring normal form and function

Inactive Publication Date: 2017-02-22
蒋科化
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, traditional Chinese medicine has many drugs for treating coronary heart disease and cerebrovascular disease caused by atherosclerosis (AS), but there are few drugs for early interventional treatment of atherosclerosis (AS). There are still few effective drugs that have combined effects of promoting blood circulation and unblocking the pulse, regulating fat and softening the pulse, and anti-inflammatory and rejuvenating the pulse. It is worth further exploration

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1: a kind of medicine for the treatment of atherosclerosis, is characterized in that being made up of the following Chinese herbal medicine raw materials in parts by weight: 9 parts of salvia miltiorrhiza, 6 parts of angelica, 3 parts of frankincense, 3 parts of myrrh, 15 parts of hawthorn root, tea tree 9 parts of root, 15 parts of corn silk, 15 parts of Gangmegen, 6 parts of Pueraria root, 3 parts of Xu Changqing, and 9 parts of Gualou skin.

Embodiment 2

[0025] Embodiment 2: a kind of medicine for the treatment of atherosclerosis, is characterized in that being made up of the following Chinese herbal medicine raw materials in parts by weight: 30 parts of salvia miltiorrhiza, 20 parts of angelica, 12 parts of frankincense, 15 parts of myrrh, 60 parts of hawthorn root, tea tree 15 parts of root, 30 parts of corn silk, 30 parts of Gangmegen, 15 parts of Pueraria root, 12 parts of Xu Changqing, 30 parts of Gualou skin.

Embodiment 3

[0026] Embodiment 3: a kind of medicine for treating atherosclerosis, it is characterized in that being made up of the following Chinese herbal medicine raw materials in parts by weight: 20 parts of salvia miltiorrhiza, 12 parts of angelica, 9 parts of frankincense, 12 parts of myrrh, 45 parts of hawthorn root, tea tree 12 parts of root, 20 parts of corn silk, 20 parts of Gangmegen, 12 parts of Pueraria root, 9 parts of Xu Changqing, 20 parts of Gualou skin.

[0027] Decoction decoction and usage and dosage: according to Example 3, select Chinese herbal medicine decoction pieces for one person's daily dosage, put the raw materials in a clay pot or ceramic pot, add water seven times the total amount of medicinal materials for the first time and decoct for one and a half hours, take Filtrate; Add five times of the total amount of medicine for decocting for an hour for the second time, get the filtrate, add three times of the total medicine amount for the third time and decoct for...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine and particularly provides a medicine for treating atherosclerosis. The medicine is characterized by being prepared from the following Chinese herbal medicine raw materials in parts by weight: 9-30 parts of radix salviae miltiorrhizae, 6-20 parts of Chinese angelica, 3-12 parts of frankincense, 3-15 parts of myrrh, 15-60 parts of hawthorn roots, 9-15 parts of tea tree roots, 15-30 parts of corn stigmas, 15-30 parts of radix ilicis asprellae, 6-15 parts of radix puerariae, 3-12 parts of radix cynanchi paniculati and 9-30 parts of snakegourd peels. The medicine with the prescription can be used for effectively treating atherosclerosis through synergistic effects of activating blood to dredge vessels, regulating lipid and softening blood vessels, and diminishing inflammation and restoring pulses; and the medicine has an obvious clinical effect, is nontoxic and safe, and has a few of untoward effects.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine for treating atherosclerosis. Background technique [0002] Atherosclerosis (AS) is characterized by lesions starting from the arterial intima, followed by lipid and complex carbohydrate accumulation, thrombus formation, fibrous tissue hyperplasia, and calcinosis. And there is gradual degeneration and calcification of the arterial media. Atherosclerosis (AS) is a chronic inflammatory process caused by multiple factors and characterized by highly specific cellular molecular responses. The main factors are dyslipidemia, hypertension, smoking, diabetes, obesity, age factors and genetic factors and so on. The pathogenesis is vascular endothelial injury, lipid accumulation and fibrous atheromatous plaque formation. Atherosclerosis (AS) mainly causes lesions in the entire circulatory system or individual organs, such as coronary heart disease and cerebrovascular disease. Data show that After...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P9/10
CPCA61K36/185A61K36/232A61K36/27A61K36/324A61K36/328A61K36/428A61K36/488A61K36/537A61K36/734A61K36/82A61K36/899A61K2300/00
Inventor 吴福
Owner 蒋科化
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com